Products
Paclitaxel, a new anticancer agent first isolated from the bark of Taxus brevifolia, has a wide spectrum of antineoplastic activity. It has in vitro cytotoxicity against human ovary, breast, cervical, pancreas, prostate, head and neck, colon, gastric, bladder, lung and CNS cancers, melanoma, hepatom
More...
Paclitaxel, a new anticancer agent first isolated from the bark of Taxus brevifolia, has a wide spectrum of antineoplastic activity. It has in vitro cytotoxicity against human ovary, breast, cervical, pancreas, prostate, head and neck, colon, gastric, bladder, lung and CNS cancers, melanoma, hepatom
More...